Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-16
2006-05-16
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S844000, C549S315000, C549S317000
Reexamination Certificate
active
07045546
ABSTRACT:
Novel derivatives of ascorbic acid and compositions comprising them are provided. The novel derivatives are of the following general formula (I): where R1 is a C2–C22 saturated or unsaturated fatty acid residues, amino acid residues, or a C1–C17 alkyl ; R2 is a group of the following formula (II) wherein R5 or R6 are the same or different and represent hydrogen, a C1–C4 alkyl, or R5 is C1–C4 alkyl group and R6 is a metal cation or ammonium cation; R3 or R4 are the same or different and represent hydrogen, C2–C22 saturated or unsaturated fatty acid residues, amino acid residues, or a C1–C17 alkyl.
REFERENCES:
patent: 3671549 (1972-06-01), Hinkley
patent: 1805958 (1969-05-01), None
patent: 1668743 (1972-03-01), None
patent: 3613590 (1985-11-01), None
patent: 0875248 (1998-11-01), None
Babtsov Vladimir
Belakhov Valery
Kvitnitsky Emma
Shapiro Yury
Browdy and Neimark PLLC
Dentz Bernard
Tagra Biotechnologies Ltd.
LandOfFree
Stabilized derivatives of ascorbic acid-3-phosphate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized derivatives of ascorbic acid-3-phosphate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized derivatives of ascorbic acid-3-phosphate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3531397